Euromoney Sees FY Adj. Pre-tax Profit Significantly Ahead Of Analysts' View - Quick Facts

By RTTNews Staff Writer ✉ | Published: 10/1/2021 2:26 AM ET

Euromoney Institutional Investor Plc (ERM.L), a B2B information services provider, said that it expects adjusted profit before tax for the full year ending 30 September 2021 to be significantly ahead of analysts' expectations before the impact of IAS 38. It reflects continuing strong growth in subscriptions in Pricing, Data & Market Intelligence, especially people Intelligence, and the continuing turnaround in Asset Management.

The company stated that its financial position remains strong. Net cash at the end of August 2021 was 34.7 million pounds.

The company said it will provide a more detailed update at its full year results which will be announced on 18 November 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Editors Pick

Humana Q4 Loss Widens On Charges

Health insurer Humana Inc. reported Wednesday a net loss for the fourth quarter that slightly widened from last year, hurt primarily by charges associated with productivity initiatives, despite 6.6 percent revenue growth. Adjusted earnings for the quarter topped analysts' expectations, while quarterly revenues missed it by a whisker.

Two Rivers Coffee Recalls Peanut Butter Hot Chocolate

South Plainfield, New Jersey-based Two Rivers Coffee is recalling its peanut butter single serve hot chocolate pods citing an undeclared peanut allergen, the U.S. Food Drug Administration said. The recall involves peanut butter single serve hot chocolate pods distributed as "Brooklyn Bean Peanut Butter Cup Hot Cocoa", "Pingo Peanut Butter Cookie Hot Chocolate" and ...

Novartis Stock Down On Weak Q4 Results; Sees Growth In FY23

Shares of Novartis AG were losing around 2 percent in the early morning trading in Switzerland after the drug major reported Wednesday sharply lower profit in its fourth quarter with weak sales as well as the absence of prior year's hefty Roche income. Adjusted earnings, however, topped market estimates, while top line missed their view. Further, the company announced higher dividend...